Kanion Pharmaceutical(SH:600557) Zheng Quan Zhi Xing·2025-04-02 13:20Core Viewpoint - The report outlines the supervisory responsibilities of the Board Audit Committee of Jiangsu Kangyuan Pharmaceutical Co., Ltd. regarding the accounting firm for the year 2024, emphasizing the appointment and performance evaluation of the auditing firm, Lixin Certified Public Accountants [1][2][3]. Group 1: Basic Information of the Accounting Firm - Lixin Certified Public Accountants was founded in 1927 by Dr. Pan Xulun and is a member of the international accounting network BDO, with a registered address in Shanghai [1]. - As of the end of 2024, Lixin has 296 partners, 2,498 registered accountants, and a total of 10,021 employees, with 743 registered accountants having signed securities service audit reports [2]. Group 2: Appointment Procedures - On March 7, 2024, the company held its first meeting of the eighth Board Audit Committee and the annual general meeting, where it approved the reappointment of Lixin as the auditing firm for the 2024 financial report and internal control audit [2][3]. Group 3: Performance of the Accounting Firm - Lixin conducted the audit in accordance with the Chinese Certified Public Accountant Auditing Standards, issuing an audit report that confirmed the financial statements were prepared in accordance with accounting standards and fairly reflected the company's financial position as of December 31, 2024 [3]. - The audit committee communicated with Lixin regarding the independence of the audit team, audit plans, risk assessments, and other key audit matters throughout the audit process [2][3]. Group 4: Supervision by the Audit Committee - The audit committee held multiple meetings to discuss the audit work and preliminary audit opinions, ensuring that Lixin completed the audit work timely to facilitate the disclosure of the 2023 annual report [4][5]. - The audit committee evaluated Lixin's qualifications, professional capabilities, and independence, concluding that Lixin met the requirements for conducting the audit work [5][6]. Group 5: Overall Evaluation - The audit committee adhered to relevant regulations and effectively supervised Lixin, ensuring that the audit reports were timely, accurate, objective, and fair [6][7]. - Lixin demonstrated good professional ethics and business quality, completing the 2024 annual audit work in a timely manner [7].